By David Batka and
Kate Burke2024-03-06T15:00:00
Australia is the most populous country in Oceania, and ranks 55th globally with its population around 26 million. It also ranks consistently high in other indicators that demonstrate the country’s above-average wealth. Factors such as a skilled workforce, high-quality research infrastructure, government incentives and well developed regulatory and health technology assessment (HTA) frameworks encourage research and development (R&D) activities and continue to make Australia an attractive destination for therapeutic goods sponsors and manufacturers. Australia’s Therapeutic Goods Administration (TGA) sits at the centre of it all.
Log in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.
If you are not a TOPRA member but have already created an account to access limited free content, log in here using your registered user email and password.
LoginJoin TOPRA today and get membership until the end of 2026 for the exclusive rate of £230.
In addition to unlimited access to Regulatory Rapporteur content, as a TOPRA member you will also be able to enjoy a wide range of benefits including career boosting resources, savings on our events and training, and access to our regional networks and special interest groups.
This offer ends 30 September 2025
Become a memberRegister now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.
The peer-reviewed journal, published 11 times per year and available free to TOPRA members.
The Organisation for Professionals in Regulatory Affairs
TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org
TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70
Site powered by Webvision Cloud